Immunogenic Cell Death and Immunomodulatory Effects of Cabozantinib
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immunogenic Cell Death and Immunomodulatory Effects of Cabozantinib
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-10-21
DOI
10.3389/fonc.2021.755433
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A phase III, randomized, open-label, study (CONTACT-02) of cabozantinib plus atezolizumab versus second novel hormone therapy (NHT) in patients (pts) with metastatic, castration-resistant prostate cancer (mCRPC).
- (2021) Neeraj Agarwal et al. JOURNAL OF CLINICAL ONCOLOGY
- Prostate cancer
- (2021) Richard J. Rebello et al. Nature Reviews Disease Primers
- Immunology of Cell Death in Cancer Immunotherapy
- (2021) Lorenzo Galluzzi et al. Cells
- Prostate cancer
- (2021) Shahneen Sandhu et al. LANCET
- Combinatorial therapy in tumor microenvironment: Where do we stand?
- (2021) Smita Kumari et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- A Phase II Study of Cabozantinib and Androgen Ablation in Patients with Hormone-Naïve Metastatic Prostate Cancer
- (2020) Paul G. Corn et al. CLINICAL CANCER RESEARCH
- AXL Targeting Abrogates Autophagic Flux and Induces Immunogenic Cell Death in Drug-Resistant Cancer Cells
- (2020) Maria L. Lotsberg et al. Journal of Thoracic Oncology
- Cabozantinib in combination with atezolizumab in patients with metastatic castration-resistant prostate cancer: Results of cohort 6 of the COSMIC-021 study.
- (2020) Neeraj Agarwal et al. JOURNAL OF CLINICAL ONCOLOGY
- Consensus guidelines for the definition, detection and interpretation of immunogenic cell death
- (2020) Lorenzo Galluzzi et al. Journal for ImmunoTherapy of Cancer
- Tyrosine Kinase Inhibitors in Cancer: Breakthrough and Challenges of Targeted Therapy
- (2020) Charles Pottier et al. Cancers
- Dendritic Cells and Immunogenic Cancer Cell Death: A Combination for Improving Antitumor Immunity
- (2020) María Julia Lamberti et al. Pharmaceutics
- Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2020) C. Parker et al. ANNALS OF ONCOLOGY
- Immunomodulatory Roles of VEGF Pathway Inhibitors in Renal Cell Carcinoma
- (2020) Laure Hirsch et al. DRUGS
- Cabozantinib plus Docetaxel and Prednisone in Metastatic Castrate Resistant Prostate Cancer
- (2020) Ravi A. Madan et al. BJU INTERNATIONAL
- Exploratory Pilot Study of Circulating Biomarkers in Metastatic Renal Cell Carcinoma
- (2020) Ilaria Grazia Zizzari et al. Cancers
- Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline
- (2020) John D. Gordan et al. JOURNAL OF CLINICAL ONCOLOGY
- Recent eUpdate to the ESMO Clinical Practice Guidelines on renal cell carcinoma on cabozantinib and nivolumab for first-line clear cell renal cancer
- (2020) T. Powles ANNALS OF ONCOLOGY
- Bevacizumab-Based Chemotherapy Triggers Immunological Effects in Responding Multi-Treated Recurrent Ovarian Cancer Patients by Favoring the Recruitment of Effector T Cell Subsets
- (2019) Chiara Napoletano et al. Journal of Clinical Medicine
- Immunogenic cell death in cancer therapy: Present and emerging inducers
- (2019) Jingyi Zhou et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Crizotinib-induced immunogenic cell death in non-small cell lung cancer
- (2019) Peng Liu et al. Nature Communications
- Johnny on the Spot-Chronic Inflammation Is Driven by HMGB1
- (2019) Carolina M. Gorgulho et al. Frontiers in Immunology
- Immunotherapy and targeted therapy—the new roadmap in cancer treatment
- (2019) Kamran Shahid et al. Annals of Translational Medicine
- TK Inhibitor Pazopanib Primes DCs by Downregulation of the β-Catenin Pathway
- (2018) Ilaria Grazia Zizzari et al. Cancer Immunology Research
- Receptors That Inhibit Macrophage Activation: Mechanisms and Signals of Regulation and Tolerance
- (2018) Ranferi Ocaña-Guzman et al. Journal of Immunology Research
- Targeting VEGF/VEGFR to Modulate Antitumor Immunity
- (2018) Ju Yang et al. Frontiers in Immunology
- The ambitious role of anti angiogenesis molecules: Turning a cold tumor into a hot one
- (2018) M. Nuti et al. CANCER TREATMENT REVIEWS
- Cabozantinib Versus Mitoxantrone-prednisone in Symptomatic Metastatic Castration-resistant Prostate Cancer: A Randomized Phase 3 Trial with a Primary Pain Endpoint
- (2018) Ethan M. Basch et al. EUROPEAN UROLOGY
- Receptor Tyrosine Kinase-Targeted Cancer Therapy
- (2018) Toshimitsu Yamaoka et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Tumor-Derived Microvesicles Enhance Cross-Processing Ability of Clinical Grade Dendritic Cells
- (2018) Marco Dionisi et al. Frontiers in Immunology
- Effective combinatorial immunotherapy for castration-resistant prostate cancer
- (2017) Xin Lu et al. NATURE
- Cabozantinib Eradicates Advanced Murine Prostate Cancer by Activating Antitumor Innate Immunity
- (2017) Akash Patnaik et al. Cancer Discovery
- Synergistic Effects of Cabozantinib and EGFR-Specific CAR-NK-92 Cells in Renal Cell Carcinoma
- (2017) Qing Zhang et al. Journal of Immunology Research
- Tumor-Derived Microvesicles Modulate Antigen Cross-Processing via Reactive Oxygen Species-Mediated Alkalinization of Phagosomal Compartment in Dendritic Cells
- (2017) Federico Battisti et al. Frontiers in Immunology
- Trial watch: Immunogenic cell death induction by anticancer chemotherapeutics
- (2017) Abhishek D. Garg et al. OncoImmunology
- Communication by Extracellular Vesicles: Where We Are and Where We Need to Go
- (2016) Mercedes Tkach et al. CELL
- Phase III Study of Cabozantinib in Previously Treated Metastatic Castration-Resistant Prostate Cancer: COMET-1
- (2016) Matthew Smith et al. JOURNAL OF CLINICAL ONCOLOGY
- Mechanistic Support for Combined MET and AR Blockade in Castration-Resistant Prostate Cancer
- (2016) Yuanyuan Qiao et al. NEOPLASIA
- -Catenin Promotes Regulatory T-cell Responses in Tumors by Inducing Vitamin A Metabolism in Dendritic Cells
- (2015) Y. Hong et al. CANCER RESEARCH
- Combinatorial Strategies for the Induction of Immunogenic Cell Death
- (2015) Lucillia Bezu et al. Frontiers in Immunology
- Cabozantinib in Chemotherapy-Pretreated Metastatic Castration-Resistant Prostate Cancer: Results of a Phase II Nonrandomized Expansion Study
- (2014) Matthew R. Smith et al. JOURNAL OF CLINICAL ONCOLOGY
- TLR2-Dependent Activation of β-Catenin Pathway in Dendritic Cells Induces Regulatory Responses and Attenuates Autoimmune Inflammation
- (2014) Indumathi Manoharan et al. JOURNAL OF IMMUNOLOGY
- Dual effects of a targeted small-molecule inhibitor (cabozantinib) on immune-mediated killing of tumor cells and immune tumor microenvironment permissiveness when combined with a cancer vaccine
- (2014) Anna R Kwilas et al. Journal of Translational Medicine
- Mucus Enhances Gut Homeostasis and Oral Tolerance by Delivering Immunoregulatory Signals
- (2013) M. Shan et al. SCIENCE
- Microvesicle Cargo of Tumor-Associated MUC1 to Dendritic Cells Allows Cross-presentation and Specific Carbohydrate Processing
- (2013) A. Rughetti et al. Cancer Immunology Research
- Cabozantinib in Patients With Advanced Prostate Cancer: Results of a Phase II Randomized Discontinuation Trial
- (2012) David C. Smith et al. JOURNAL OF CLINICAL ONCOLOGY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Activity of XL184 (Cabozantinib), an Oral Tyrosine Kinase Inhibitor, in Patients With Medullary Thyroid Cancer
- (2011) Razelle Kurzrock et al. JOURNAL OF CLINICAL ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started